He began his research career as an undergraduate at the Massachusetts Institute of Technology, where he studied E. coli DNA repair under Graham C.

[5] There, he also completed a postdoctoral biochemistry fellowship with Frederick W. Alt, a Howard Hughes Medical Institute investigator, studying immunoglobulin class-switch recombination.

Stock Professor of Medicine (Immunology) and Microbiology and chief of the pulmonary, allergy and critical care division.

In 2008, he was named dean of the Carver College of Medicine and leader of its clinical practice plan, a role in which he served for four years.

[1] Rothman is on the Board of Directors of Merck and Company, as well as the King Faisal Specialist Hospital & Research Centre in Saudi Arabia.